RE:FDA's Head of CBER wants faster approvals with SE/biomarkersThe Promising Pathways Act (PPA) facilitaties the FDA's intent in accelerating drug approvals for rare diseases with unmet medical needs like pancreatic cancer.
https://stockhouse.com/companies/bullboard?symbol=t.onc&postid=35532645